AdipoR1 expression in intra-abdominal adipose tissue was not altered by obesity or diabetes

	Tweet

AdipoR1 expression in intra-abdominal adipose tissue was not altered by obesity or diabetes.

“The effects of adiponectin on glucose and lipid metabolism are mediated by the adiponectin receptors, adipoR1 and adipoR2, which are mainly in liver and muscle. We investigated the presence of adiponectin receptors in intra-abdominal adipose tissue (IAAT) in obesity and diabetes and their association with adiponectin expression and components of the metabolic syndrome and/or other metabolic factors associated with atherosclerotic cardiovascular disease (ASCVD),” investigators in Spain report.

R. Morinigo and colleagues at the Hospital Clinic University explained, “AdipoR1 and adipoR2 gene expression was measured by quantitative real time reverse transcription polymerase chain reaction in IAAT from lean and obese patients with or without diabetes type 2.

Correlation between metabolic characteristics of obese patients and expression of these receptors was studied.”

They determined, “Neither obesity nor diabetes were associated with changes in IAAT-adipoR1 expression. In contrast, IAAT-adipoR2 was decreased by 39.5% in obese nondiabetics and by 52.7% in obese diabetics when compared to lean subjects. AdipoR1 and adiponectin expression was associated in lean (r=0.943, p<0.005) and obese nondiabetic patients (r=0.74, p<0.01), whereas a positive correlation between adipoR2 and adiponectin expression was only found in the presence of diabetes (r=0.883, p<0.002).

“AdipoR1 expression was associated with plasma free fatty acids (FFA) concentration (r=0.76, p<0.04), and adipoR2 inversely correlated with plasma levels of triglycerides (r=-0.76, p<0.04) and apolipoprotein B (r=-0.74, p<0.05).”

The researchers concluded, “AdipoR1 expression in IAAT was not altered by obesity and/or diabetes and was related to plasma levels of FFA. IAAT-adipoR2 expression was reduced in obesity and diabetes and associated with components of metabolic processes leading to cardiovascular disease in obesity.”

Morinigo and colleagues published their study in Obesity Surgery (Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obes Surg, 2006;16(6):745-751).

For additional information, contact H. Corominola, Hospital Clinic University, Endocrinol & Nutrition Unit, IDIBAPS, Villarroel 170, E-08036 Barcelona, Spain.

The publisher of the journal Obesity Surgery can be contacted at: F DCommunications Inc., 3100 Bayview Avenue, Unit 4, Toronto, Ontario M2N 5L3, Canada.

RELATED STORIES:
Weight in pregnancy best controlled by diet, study shows   FDA advisers recommend approving weight loss drug   Bridal Hunger Games   Exercise, Group Support Work for Weight Loss   Misperception of weight is an important barrier to weight loss   Obesity drugs need heart studies, U.S. advisers say   Weight Loss Surgery and Diabetes: Expert Interview Opportunity   New evidence on effects of green coffee beans in weight loss   Chocolate lovers tend to weigh less: study   Weight loss won’t necessarily help teen girls’ self-esteem   How to Best Help Your Child Lose Weight: Lose Weight Yourself   Qnexa: Is the new anti-obesity drug too risky?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]